117 related articles for article (PubMed ID: 9681414)
1. Atrial natriuretic peptide gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in salt-sensitive rats.
Lin KF; Chao J; Chao L
Hum Gene Ther; 1998 Jul; 9(10):1429-38. PubMed ID: 9681414
[TBL] [Abstract][Full Text] [Related]
2. Human kallikrein gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in Dahl salt-sensitive rats.
Chao J; Zhang JJ; Lin KF; Chao L
Hum Gene Ther; 1998 Jan; 9(1):21-31. PubMed ID: 9458239
[TBL] [Abstract][Full Text] [Related]
3. Atrial natriuretic peptide gene delivery reduces stroke-induced mortality rate in Dahl salt-sensitive rats.
Lin KF; Chao J; Chao L
Hypertension; 1999 Jan; 33(1 Pt 2):219-24. PubMed ID: 9931108
[TBL] [Abstract][Full Text] [Related]
4. Encapsulated transgene cells attenuate hypertension, cardiac hypertrophy and enhance renal function in Goldblatt hypertensive rats.
Chen LG; Wang ZR; Wan CM; Chao L; Chao J; Xing HY
J Gene Med; 2004 Jul; 6(7):786-97. PubMed ID: 15241786
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated kallikrein gene delivery reverses salt-induced renal injury in Dahl salt-sensitive rats.
Chao J; Zhang JJ; Lin KF; Chao L
Kidney Int; 1998 Oct; 54(4):1250-60. PubMed ID: 9767541
[TBL] [Abstract][Full Text] [Related]
6. Human adrenomedullin gene delivery protects against cardiac hypertrophy, fibrosis, and renal damage in hypertensive dahl salt-sensitive rats.
Zhang JJ; Yoshida H; Chao L; Chao J
Hum Gene Ther; 2000 Sep; 11(13):1817-27. PubMed ID: 10986555
[TBL] [Abstract][Full Text] [Related]
7. Atrial natriuretic peptide gene delivery attenuates gentamycin-induced nephrotoxicity in rats.
Murakami H; Yayama K; Chao J; Chao L
Nephrol Dial Transplant; 1999 Jun; 14(6):1376-84. PubMed ID: 10382996
[TBL] [Abstract][Full Text] [Related]
8. Experimental kallikrein gene therapy in hypertension, cardiovascular and renal diseases.
Chao J; Chao L
Pharmacol Res; 1997 Jun; 35(6):517-22. PubMed ID: 9356201
[TBL] [Abstract][Full Text] [Related]
9. Gestational hypertension in atrial natriuretic peptide knockout mice and the developmental origins of salt-sensitivity and cardiac hypertrophy.
Armstrong DW; Tse MY; O'Tierney-Ginn PF; Wong PG; Ventura NM; Janzen-Pang JJ; Matangi MF; Johri AM; Croy BA; Adams MA; Pang SC
Regul Pept; 2013 Sep; 186():108-15. PubMed ID: 23981445
[TBL] [Abstract][Full Text] [Related]
10. Adrenomedullin gene delivery attenuates hypertension, cardiac remodeling, and renal injury in deoxycorticosterone acetate-salt hypertensive rats.
Dobrzynski E; Wang C; Chao J; Chao L
Hypertension; 2000 Dec; 36(6):995-1001. PubMed ID: 11116114
[TBL] [Abstract][Full Text] [Related]
11. Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure.
Wolf WC; Yoshida H; Agata J; Chao L; Chao J
Kidney Int; 2000 Aug; 58(2):730-9. PubMed ID: 10916096
[TBL] [Abstract][Full Text] [Related]
12. Human adrenomedullin gene delivery protects against cardiovascular remodeling and renal injury.
Chao J; Kato K; Zhang JJ; Dobrzynski E; Wang C; Agata J; Chao L
Peptides; 2001 Nov; 22(11):1731-7. PubMed ID: 11754958
[TBL] [Abstract][Full Text] [Related]
13. Adrenomedullin gene delivery attenuates renal damage and cardiac hypertrophy in Goldblatt hypertensive rats.
Wang C; Dobrzynski E; Chao J; Chao L
Am J Physiol Renal Physiol; 2001 Jun; 280(6):F964-71. PubMed ID: 11352835
[TBL] [Abstract][Full Text] [Related]
14. Human atrial natriuretic peptide gene delivery reduces blood pressure in hypertensive rats.
Lin KF; Chao J; Chao L
Hypertension; 1995 Dec; 26(6 Pt 1):847-53. PubMed ID: 7490138
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated kallikrein gene delivery attenuates hypertension and protects against renal injury in deoxycorticosterone-salt rats.
Dobrzynski E; Yoshida H; Chao J; Chao L
Immunopharmacology; 1999 Oct; 44(1-2):57-65. PubMed ID: 10604525
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of vascular smooth muscle cell proliferation and migration in vitro and neointimal hyperplasia in vivo by adenoviral-mediated atrial natriuretic peptide delivery.
Larifla L; Déprez I; Pham I; Rideau D; Louzier V; Adam M; Eloit M; Foucan L; Adnot S; Teiger E
J Gene Med; 2012 Jul; 14(7):459-67. PubMed ID: 22645072
[TBL] [Abstract][Full Text] [Related]
17. Regulatable atrial natriuretic peptide gene therapy for hypertension.
Schillinger KJ; Tsai SY; Taffet GE; Reddy AK; Marian AJ; Entman ML; Oka K; Chan L; O'Malley BW
Proc Natl Acad Sci U S A; 2005 Sep; 102(39):13789-94. PubMed ID: 16162668
[TBL] [Abstract][Full Text] [Related]
18. [Encapsulated ANP cDNA transfection cells attenuate hypertension in hypertensive rats].
Chen LG; Qu Y; Peng WZ; Wang YQ; Xiao J; Wang ZR
Space Med Med Eng (Beijing); 2003 Feb; 16(1):77-8. PubMed ID: 12728966
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy in hypertension: adenovirus-mediated kallikrein gene delivery in hypertensive rats.
Jin L; Zhang JJ; Chao L; Chao J
Hum Gene Ther; 1997 Oct; 8(15):1753-61. PubMed ID: 9358025
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects of the combination of levosimendan and valsartan in hypertensive Dahl/Rapp rats.
Biala A; Finckenberg P; Korpi A; Loytainen M; Martonen E; Levijoki J; Mervaala E
J Physiol Pharmacol; 2011 Jun; 62(3):275-85. PubMed ID: 21893687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
